HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazushige Mizoguchi Selected Research

1,25-dihydroxyvitamin D

2/2010Systemic disorders of calcium dynamics in rats with adenine-induced renal failure: implication for chronic kidney disease-related complications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazushige Mizoguchi Research Topics

Disease

7Alzheimer Disease (Alzheimer's Disease)
07/2022 - 08/2007
6Dementia (Dementias)
10/2021 - 05/2015
6Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020 - 08/2013
2Frailty
06/2022 - 01/2020
2Anorexia
01/2022 - 10/2021
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 01/2010
1Multiple Sclerosis
05/2022
1Disease Progression
05/2022
1Leukoencephalopathies
02/2021
1Anhedonia
01/2021
1Pelizaeus-Merzbacher Disease
10/2020
1Cognitive Dysfunction
01/2020
1Anxiety Disorders (Anxiety Disorder)
01/2020
1Thiamine Deficiency
01/2019
1Dyskinesias (Dyskinesia)
01/2016
1Demyelinating Diseases (Demyelinating Disease)
01/2016
1Hallucinations (Hallucination)
05/2015
1Pheochromocytoma
01/2014
1Chronic Renal Insufficiency
02/2010
1Renal Insufficiency (Renal Failure)
02/2010
1Liver Diseases (Liver Disease)
01/2010

Drug/Important Bio-Agent (IBA)

11Yi-Gan SanIBA
01/2019 - 01/2010
4ninjin'yoeitoIBA
06/2022 - 01/2021
2Glutamic Acid (Glutamate)FDA Link
01/2019 - 01/2014
2Pharmaceutical PreparationsIBA
12/2018 - 05/2015
1RNA (Ribonucleic Acid)IBA
07/2022
1CytokinesIBA
05/2022
1Interleukin-6 (Interleukin 6)IBA
05/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2022
1Dopamine (Intropin)FDA LinkGeneric
10/2021
1EnzymesIBA
10/2021
1Mutant Proteins (Protein, Mutant)IBA
02/2021
1Proteins (Proteins, Gene)FDA Link
02/2021
1FilaminsIBA
02/2021
1Sucrose (Saccharose)IBA
01/2021
1Dopamine Receptors (Dopamine Receptor)IBA
01/2021
1Phosphotransferases (Kinase)IBA
10/2020
1kamikihi-to (KKT)IBA
01/2020
1Memantine (Namenda)FDA Link
12/2018
1Ether (Diethyl Ether)IBA
01/2018
1Indole AlkaloidsIBA
01/2018
1geissoschizineIBA
01/2018
1Plant ExtractsIBA
01/2016
1Levodopa (L Dopa)FDA LinkGeneric
01/2016
1BenserazideIBA
01/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1Hallucinogens (Psychedelics)IBA
05/2015
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
05/2015
1Cystine (L-Cystine)IBA
01/2014
1AntiportersIBA
01/2014
1CreatinineIBA
02/2010
1Parathyroid Hormone (Parathormone)IBA
02/2010
1CalciumIBA
02/2010
1NitrogenIBA
02/2010
1collagen type I trimeric cross-linked peptideIBA
02/2010
11,25-dihydroxyvitamin DIBA
02/2010
1MineralsIBA
02/2010
1Collagen Type I (Type I Collagen)IBA
02/2010
1Urea (Carbamide)FDA LinkGeneric
02/2010
1AdenineFDA LinkGeneric
02/2010
1Amyloid beta-PeptidesIBA
08/2007

Therapy/Procedure

14Kampo Medicine (Kampo)
01/2022 - 01/2010
1Oral Administration
01/2016